Table 2 Mean diagnostic performance of causal modeling predictions in the testing set, across all evaluations performed in 4 Cohorts 1–4

From: Large scale causal modeling to identify adults at risk for combined and common variable immunodeficiencies

Patient cohorts

Metric trained on (column)/Predicted on (row)

Cohort 1

Cohort 2

Cohort 3

Cohort 4

Sensitivity

Cohort 1

0.84 (0.00)

0.69 (0.01)

0.78 (0.00)

0.79 (0.00)

Cohort 2

0.83 (0.00)

0.70 (0.00)

0.81 (0.00)

0.78 (0.00)

Cohort 3

0.74 (0.00)

0.67 (0.00)

0.88 (0.00)

0.76 (0.00)

Cohort 4

0.76 (0.00)

0.66 (0.01)

0.69 (0.00)

0.78 (0.00)

Specificity

Cohort 1

0.69 (0.00)

0.63 (0.00)

0.62 (0.00)

0.61 (0.00)

Cohort 2

0.67 (0.00)

0.75 (0.01)

0.63 (0.01)

0.61 (0.00)

Cohort 3

0.55 (0.01)

0.55 (0.01)

0.59 (0.00)

0.56 (0.00)

Cohort 4

0.54 (0.01)

0.54 (0.01)

0.55 (0.00)

0.55 (0.00)

Accuracy

Cohort 1

0.75 (0.00)

0.65 (0.00)

0.67 (0.00)

0.66 (0.01)

Cohort 2

0.73 (0.00)

0.72 (0.00)

0.69 (0.00)

0.66 (0.00)

Cohort 3

0.58 (0.01)

0.57 (0.00)

0.65 (0.00)

0.59 (0.01)

Cohort 4

0.57 (0.01)

0.56 (0.01)

0.58 (0.00)

0.59 (0.00)

ROC AUC

Cohort 1

0.77 (0.01)

0.66 (0.00)

0.71 (0.00)

0.65 (0.00)

Cohort 2

0.72 (0.00)

0.75 (0.00)

0.72 (0.01)

0.65 (0.00)

Cohort 3

0.58 (0.01)

0.59 (0.00)

0.63 (0.00)

0.56 (0.00)

Cohort 4

0.57 (0.00)

0.56 (0.01)

0.59 (0.00)

0.61 (0.00)

  1. Within cohort evaluations in the held-out fold test set are shown with bold. Parentheses show standard deviation.